Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0200
0.00 (0.00%)
At close: Oct 29, 2026

SGXC:9G2 Revenue

In the fiscal year ending June 30, 2026, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.72M SGD with 0.05% growth. Singapore Institute of Advanced Medicine Holdings had revenue of 3.28M in the quarter ending June 30, 2026, a decrease of -11.93%. That makes Singapore Institute of Advanced Medicine Holdings the 36,377th largest company in the world by revenue and 436th in Singapore.

Revenue
15.72M
Revenue Growth
+0.05%
P/S Ratio
2.41
Revenue / Employee
151.13K
Employees
104
Market Cap
34.48M

Revenue Chart

Revenue by Segment

  • Medical Diagnostics and Treatments 12.52M 79.7%
  • Radiation Therapy and Medical Oncology Services 3.19M 20.3%
Fiscal year ended Jun 30, 2026 See the full SGXC:9G2 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202615.72M8.38K0.05%
Jun 30, 202515.71M-936.78K-5.63%
Jun 30, 202416.65M412.41K2.54%
Jun 30, 202316.23M2.43M17.56%
Jun 30, 202213.81M891.35K6.90%
Jun 30, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.